Trial intelligence / Profile preview

Yigu Capsule in Postmenopausal Osteoporosis (Kidney Yang Deficiency)

CTR20140585Phase 2Active

Sponsor
Shijia Jiushengyuan
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of zoledronic acid in osteoporosis, sponsored by Shijia Jiushengyuan. Started Sep 2014; status: active.

02

Drugs

zoledronic acid
03

Conditions

osteoporosis

Beyond the preview

Go deeper on CTR20140585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call